Media Coverage

Sigrid Therapeutics nya VD på plats – fokus på kommersiell uppskalning

Nov 16, 2026

Media: BioStock

Featuring: Claus Kjærsgaard

In an interview with BioStock, new CEO Claus Kjærsgaard sets out Sigrid’s priorities: commercial scaling and market expansion.

Leadership strategyCommercialisationMarket growth
Sigrid Therapeutics nya VD på plats – fokus på kommersiell uppskalning
Read the full article

Shortly after taking over as CEO, Claus Kjærsgaard spoke with BioStock about Sigrid’s strategic priorities, with commercial scale-up and market expansion for SiPore® at the centre of the plan.

← Back to all insights